Christopher Weldon MD PhD

Christopher Weldon, MD, PhD

Assistant in Surgery; Director, Pediatric Surgery Critical Care Fellowship

Assistant Professor of Surgery, Harvard Medical School

    Contact: 617-355-4503
  • Fax: 617-730-0477

Medical Services

Specialties

  • Hematology Oncology
  • Surgical Critical Care
  • Breast disorders
  • Lymph Node disorders
  • Melanoma
  • Circumcision
  • Undescended Testicles

Departments

  • Surgery
  • Hematology / Oncology

Programs

  • Surgical Critical Care Program
To schedule an appointment: Call 617-355-4503 or Request an Appointment

Experience and Education

Education

Undergraduate School

University of Notre Dame, 1991

South Bend, Indiana

Graduate School

Tulane University, 2001

New Orleans, Louisiana

Medical School

Tulane University School of Medicine, University Health Sciences Center, 1995

New Orleans, Louisiana

Internship

Tulane University Health Sciences Center, 1995

New Orleans, Louisiana

Residency

Tulane University Health Sciences Center, 1996

New Orleans, Louisiana

Fellowship, Critical Care

Tulane University, 2003

New Orleans, Louisiana

Fellowship, Pediatric Surgery

Boston Children's Hospital, 2004

Boston, MA

Certifications

  • Surgical Critical Care, General Surgery, Pediatric Surgery

Publications

Publications powered by Harvard Catalyst Profiles
  1. Devji TF, Madenci AL, Carpino E, Leahy IC, Samnaliev M, Dearden JL, Weil BR, Weldon CB, Cravero J. Safety and cost-effectiveness of port removal outside of the operating room among pediatric patients. J Pediatr Surg. 2016 Nov; 51(11):1891-1895.
  2. Boikos SA, Pappo AS, Killian JK, LaQuaglia MP, Weldon CB, George S, Trent JC, von Mehren M, Wright JA, Schiffman JD, Raygada M, Pacak K, Meltzer PS, Miettinen MM, Stratakis C, Janeway KA, Helman LJ. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic. JAMA Oncol. 2016 Jul 1; 2(7):922-8.
  3. Madenci AL, Levine BS, Laufer MR, Boyd TK, Voss SD, Zurakowski D, Frazier AL, Weldon CB. Preoperative risk stratification of children with ovarian tumors. J Pediatr Surg. 2016 Sep; 51(9):1507-12.
  4. Madenci AL, Levine BS, Laufer MR, Boyd TK, Voss SD, Frazier AL, Weldon CB. Poor adherence to staging guidelines for children with malignant ovarian tumors. J Pediatr Surg. 2016 Sep; 51(9):1513-7.
  5. Madenci AL, Fisher S, Diller LR, Goldsby RE, Leisenring WM, Oeffinger KC, Robison LL, Sklar CA, Stovall M, Weathers RE, Armstrong GT, Yasui Y, Weldon CB. Intestinal Obstruction in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study. J Clin Oncol. 2015 Sep 10; 33(26):2893-900.
  6. Mazziotti MV, Weldon CB, Lopez ME, Abbas PI, Rescorla FJ, Kim ES. Analysis of submitted abstracts for the American Academy of Pediatrics, Section on Surgery, National Conference (AAP SoSU). J Pediatr Surg. 2015 Jun; 50(6):1058-61.
  7. Zalieckas J, Weldon C. Sedation and analgesia in the ICU. Semin Pediatr Surg. 2015 Feb; 24(1):37-46.
  8. Madenci AL, Lehmann LE, Weldon CB. Surgical consultation and intervention during pediatric hematopoietic stem cell transplantation. Pediatr Transplant. 2014 Dec; 18(8):875-81.
  9. Liew WK, Powell CA, Sloan SR, Shamberger RC, Weldon CB, Darras BT, Kang PB. Comparison of plasmapheresis and intravenous immunoglobulin as maintenance therapies for juvenile myasthenia gravis. JAMA Neurol. 2014 May; 71(5):575-80.
  10. Madenci AL, Stoffan AP, Rajagopal SK, Blinder JJ, Emani SM, Thiagarajan RR, Weldon CB. Factors associated with survival in patients who undergo peritoneal dialysis catheter placement following cardiac surgery. J Pediatr Surg. 2013 Jun; 48(6):1269-76.
  11. Show all
  12. Madenci AL, Thiagarajan RR, Stoffan AP, Emani SM, Rajagopal SK, Weldon CB. Characterizing peritoneal dialysis catheter use in pediatric patients after cardiac surgery. J Thorac Cardiovasc Surg. 2013 Aug; 146(2):334-8.
  13. Frazier AL, Weldon C, Amatruda J. Fetal and neonatal germ cell tumors. Semin Fetal Neonatal Med. 2012 Aug; 17(4):222-30.
  14. Weldon CB, Tsui JH, Shankarappa SA, Nguyen VT, Ma M, Anderson DG, Kohane DS. Electrospun drug-eluting sutures for local anesthesia. J Control Release. 2012 Aug 10; 161(3):903-9.
  15. Janeway KA, Weldon CB. Pediatric gastrointestinal stromal tumor. Semin Pediatr Surg. 2012 Feb; 21(1):31-43.
  16. Klein JD, Turner CG, Gray FL, Yu DC, Kozakewich HP, Perez-Atayde AR, Voss SD, Zurakowski D, Shamberger RC, Weldon CB. Adrenal cortical tumors in children: factors associated with poor outcome. J Pediatr Surg. 2011 Jun; 46(6):1201-7.
  17. Weldon C, Tian B, Kohane DS. Nanotechnology for surgeons. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 May-Jun; 3(3):223-8.
  18. Mariño-Enríquez A, Ou WB, Weldon CB, Fletcher JA, Pérez-Atayde AR. ALK rearrangement in sickle cell trait-associated renal medullary carcinoma. Genes Chromosomes Cancer. 2011 Mar; 50(3):146-53.
  19. Yu DC, Grabowski MJ, Kozakewich HP, Perez-Atayde AR, Voss SD, Shamberger RC, Weldon CB. Primary lung tumors in children and adolescents: a 90-year experience. J Pediatr Surg. 2010 Jun; 45(6):1090-5.
  20. Rosen H, Webb ML, DiVasta AD, Greene AK, Weldon CB, Kozakewich H, Perez-Atayde AR, Labow BI. Adolescent gynecomastia: not only an obesity issue. Ann Plast Surg. 2010 May; 64(5):688-90.
  21. Yu DC, Kozakewich HP, Perez-Atayde AR, Shamberger RC, Weldon CB. Childhood pancreatic tumors: a single institution experience. J Pediatr Surg. 2009 Dec; 44(12):2267-72.
  22. Yu DC, Grabowski MJ, Feins NR, Weldon CB. H-type rectovaginal fistula in a patient with bilateral single ectopic ureters. J Pediatr Surg. 2009 Oct; 44(10):e27-30.
  23. Misra MV, Smithers CJ, Krawczuk LE, Jenkins RL, Linden BC, Weldon CB, Kim HB. Reduced size liver transplantation from a donor supported by a Berlin Heart. Am J Transplant. 2009 Nov; 9(11):2641-3.
  24. Fitzgibbons SC, Ching Y, Yu D, Carpenter J, Kenny M, Weldon C, Lillehei C, Valim C, Horbar JD, Jaksic T. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg. 2009 Jun; 44(6):1072-5; discussion 1075-6.
  25. Yu DC, Thiagarajan RR, Laussen PC, Laussen JP, Jaksic T, Weldon CB. Outcomes after the Ladd procedure in patients with heterotaxy syndrome, congenital heart disease, and intestinal malrotation. J Pediatr Surg. 2009 Jun; 44(6):1089-95; discussion 1095.
  26. Yu DC, Javid PJ, Chikwava KR, Kozakewich HP, Debiec-Rychter M, Lillehei CW, Weldon CB. Mesenteric lipoblastoma presenting as a segmental volvulus. J Pediatr Surg. 2009 Feb; 44(2):e25-8.
  27. Yu DC, Linden BC, Anderson ME, Weldon CB. Use of a distal arteriovenous fistula in a complex vascular reconstruction after resection of an osteosarcoma in a high-risk child. J Pediatr Surg. 2009 Feb; 44(2):459-63.
  28. Gutweiler JR, Labelle J, Suh MY, Misra MV, Ahmed M, Lee EY, Vargas SO, Kim HB, Weldon CB. A familial case of pleuropulmonary blastoma. Eur J Pediatr Surg. 2008 Jun; 18(3):192-4.
  29. Weldon CB, Shamberger RC. Pediatric pulmonary tumors: primary and metastatic. Semin Pediatr Surg. 2008 Feb; 17(1):17-29.
  30. Weldon CB, Shamberger RC. Pediatric Pulmonary Tumors. Seminars in Pediatric Surgery. 2008; in press..
  31. Hendren WH, Weldon CB. Congenital Esophageal Disorders. Operative Thoracic Surgery. 2008; in press/submitted..
  32. Gutweiler JR, LaBelle J, Suh MY, Misra MV, Ahmed M, Lee EY, Vargas SO, Kim HB, Weldon CB. A Familial Case of Pleuropulmonary Blastoma. European Journal of Pediatric Surgery. 2008; in press..
  33. Anderson ME, Gebhardt MC, Weldon CB, Shamberger RC. Surgical Aspects of Pediatric Oncology. Nathan and Oski’s Pediatric Hematology and Oncology. 2008; in press/submitted..
  34. Frigo DE, Basu A, Nierth-Simpson EN, Weldon CB, Dugan CM, Elliott S, Collins-Burow BM, Salvo VA, Zhu Y, Melnik LI, Lopez GN, Kushner PJ, Curiel TJ, Rowan BG, McLachlan JA, Burow ME. p38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein 1. Mol Endocrinol. 2006 May; 20(5):971-83.
  35. Frigo DE, Basu A, Nierth-Simpson EN, Weldon CB, Dugan CM, Elliot S, Collins-Burow BM, Salvo VA, Zhu Y, melnik LI, Lopez GN, Kushner PJ, Curiel TJ, Rowan BG, McLachlan JA, Burow, ME. P38 mitogen-activated protein kinase stimulates estrogen-mediated transcription and proliferation through the phosphorylation and potentiation of the p160 coactivator glucocorticoid receptor-interacting protein1. Molecular Endocrinology,. 2006; 20(5):971-983..
  36. Weldon CB, McKee A, Collins-Burow BM, Melnik LI, Scandurro AB, McLachlan JA, Burow ME, Beckman BS. PKC-mediated survival signaling in breast carcinoma cells: a role for MEK1-AP1 signaling. Int J Oncol. 2005 Mar; 26(3):763-8.
  37. Nichols RL, Choe EU, Weldon CB. Mechanical and antibacterial bowel preparation in colon and rectal surgery. Chemotherapy. 2005; 51 Suppl 1:115-21.
  38. Weldon CB, Elliott S, Zhu Y, Clayton JL, Curiel TJ, Jaffe BM, Burow ME. Regulation of estrogen-mediated cell survival and proliferation by p160 coactivators. Surgery. 2004 Aug; 136(2):346-54.
  39. Weldon CB, Parker AP, Patten D, Elliott S, Tang Y, Frigo DE, Dugan CM, Coakley EL, Butler NN, Clayton JL, Alam J, Curiel TJ, Beckman BS, Jaffe BM, Burow ME. Sensitization of apoptotically-resistant breast carcinoma cells to TNF and TRAIL by inhibition of p38 mitogen-activated protein kinase signaling. Int J Oncol. 2004 Jun; 24(6):1473-80.
  40. Madan AK, Weldon CB, Long WP, Johnson D, Raafat A. Solid and papillary epithelial neoplasm of the pancreas. J Surg Oncol. 2004 Mar 15; 85(4):193-8.
  41. Simstein R, Burow M, Parker A, Weldon C, Beckman B. Apoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp Biol Med (Maywood). 2003 Oct; 228(9):995-1003.
  42. Hopson LR, Hirsh E, Delgado J, Domeier RM, Krohmer J, McSwain NE, Weldon C, Friel M, Hoyt DB. Guidelines for withholding or termination of resuscitation in prehospital traumatic cardiopulmonary arrest. J Am Coll Surg. 2003 Mar; 196(3):475-81.
  43. Weldon CB, Parker AP, Patten D, Elliot S, Tang Y, Frigo DE, Butler NN, Clayton JL, Alam J, Curiel TJ, Beckman BS, Jaffe BM, Burow ME. Sensitization of Apoptotically Resistant Breast Carcinoma Cells to TNF and TRAIL by Inhibition of P38 Mitogen-Activated Protein Kinase Signaling. Proceedings of the Society of Surgical Oncology. 2003.
  44. Hopson lr, Hirch E, Delgado J, Domeier RM, Krohmer J, McSwain NE Jr, Weldon C, Friel M, Hoyt DB; National Association of EMS Physicians Standards and Clinical Practice Committee, American College of Surgeons Committee on Trauma. Guidelines for withholding or termination of resuscitation in prehospital cardiopulmonary arrest. Journal of American College of Surgeons,. 2003; 196(3):475-81..
  45. Weldon CB, Jaffe BM, Kahn MJ. Therapy-induced leukemias and myelodysplastic syndromes after breast cancer treatment: an underemphasized clinical problem. Ann Surg Oncol. 2002 Oct; 9(8):738-44.
  46. Weldon CB, Silberfein E, Chehardy PL, McSwain NE. ATLS training: a novel approach. Bull Am Coll Surg. 2002 Apr; 87(4):15-9.
  47. Weldon CB, Siberfein E, Chehardy PL, McSwain NE. Advanced Trauma Life Support Training: A novel approach. Bulletin of the American College of Surgeons,. 2002; 87(4):15-19..
  48. Weldon CB, Jaffe BM, Kahn ML. Therapy-induced leukemias and myelodysplastic syndromes following breast cancer treatment. Ann Surgical Oncology. 2002; 9(8):738-744.
  49. Weldon CB, Scandurro AB, Rolfe KW, Clayton JL, Butler NN, Melnik LI, Alam J, McLachlan JA, Jaffe BM, Beckman BS, Burow ME. Identification of mitogen-activated protein kinase kinase 5 (mek5) as a chemoresistance pathway in MCF-7 cells using gene expression microarray. Basic Science Plenary Session, Proceedings of the Society of University Surgeons. 2002.
  50. Weldon CB, Scandurro AB, Rolfe KW, Clayton JL, Elliot S, Butler NN, Melnik LI, Alam J, McLachlan JA, Jaffe BM, Beckman BS, Burow ME . Identification of mitogen-activated protein kinase kinase 5 (MEK5) as a chemoresistance pathway in MCF-7 cells using gene expression microarray. Surgery,. 2002; 132(2):292-301..
  51. Burow ME, Weldon CB, Tang Y, McLachlan JA, Beckman BS. Oestrogen-mediated suppression of tumour necrosis factor alpha-induced apoptosis in MCF-7 cells: subversion of Bcl-2 by anti-oestrogens. J Steroid Biochem Mol Biol. 2001 Nov; 78(5):409-18.
  52. Weldon CB, Burow ME, Rolfe KW, Clayton JL, Jaffe BM, Beckman BS. NF-kappa B-mediated chemoresistance in breast cancer cells. Surgery. 2001 Aug; 130(2):143-50.
  53. Madan AK, Long AE, Weldon CB, Jaffe BM. Esophageal carcinosarcoma. J Gastrointest Surg. 2001 Jul-Aug; 5(4):414-7.
  54. Weldon CB*, Burow ME*, Yan T, McLachlan JA, Beckman BS. *co-first authorship. Oestrogen-mediated suppression of TNF-induced apoptosis in MCF-7 cells:subversion of Bcl-2 by antioestrogens. Journal of Ster Biochemistry Mol Biol.,. 2001; 78(5):409-418..
  55. Weldon CB, Burow ME, Jaffe BM, Beckman BS. NF-kappa â-mediated chemoresistance in breast cancer cells. Proceedings of the Society of University Surgeons. 2001.
  56. Weldon CB, Friel MT, Clayton JL, McSwain NE. Pre-hospital DNR Protocol: An idea whose time has arrived. Winner, Clinical Trauma Paper Competition. Louisiana State Committee on Trauma. Resident Paper Competition. 2001.
  57. Weldon CB. Identification and analysis of molecular mechanisms of chemoresistance in human breast carcinoma cells. 2001.
  58. Weldon CB, Burow ME, Beckman BS, Jaffe BM. Identification of chemoresisstance targets in MCF-7 cells using gene microarray. Proceedings of the Society of Surgical Oncology. 2001.
  59. Madan AK, Long AE, Weldon CB, Jaffe BM. Esophageal carcinosarcoma. Journal of Gastrointestinal Surgery. 2001; 5(4):414-417..
  60. Burow ME, Weldon CB, Chiang TC, Tang Y, Collins-Burow BM, Rolfe K, Li S, McLachlan JA, Beckman BS. Differences in protein kinase C and estrogen receptor alpha, beta expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. Int J Oncol. 2000 Jun; 16(6):1179-87.
  61. Burow ME, Weldon CB, Melnik LI, Duong BN, Collins-Burow BM, Beckman BS, McLachlan JA. PI3-K/AKT regulation of NF-kappaB signaling events in suppression of TNF-induced apoptosis. Biochem Biophys Res Commun. 2000 May 10; 271(2):342-5.
  62. Burow ME, Weldon CB, Collins-Burow BM, Ramsey N, McKee A, Klippel A, McLachlan JA, Clejan S, Beckman BS. Cross-talk between phosphatidylinositol 3-kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. J Biol Chem. 2000 Mar 31; 275(13):9628-35.
  63. Beckman BS, Weldon CB, Clejan S, Rolfe KW, Hammond TG, Burow ME . Modulation of apoptotic pathways for therapeutic advantage: MCF-7 cells as a model system. Proceedings of the 5th Annual Multidisciplinary Symposium on Breast Disease. 2000.
  64. Weldon CB, Burow ME, Clejan S, Rolfe K, Hammond TG, Beckman BS. Modulation of apoptotic pathways for therapeutic advantage in breast cancer. Proceedings of the American Society for Pharmacology and Experimental Therapeutics. 2000; 14(A1516).
  65. Weldon CB*, Burrow ME*, Chiang, TC, Tang Y, Collins-Burow BM, Rolfe K, Li S, McLachlan JA, Beckman BS. *co-first authorship. Differences in protein kinase C and estrogen receptor á, â expression and signaling correlate with apoptotic sensitivity of MCF-7 breast cancer cell variants. International Journal of Oncology,. 2000; 16(6):1179-1187..
  66. Weldon CB*, Burow ME*, Melnik L, Duong B, Collins-Burow BM, Klippel A, Beckman BS, McLachlan JA. *co-first authorship. Phosphatidylinositol 3-kinase/Akt mediated regulation of NF-êB signaling events as a mechanism for suppression of TNF-induced apoptosis. Biochemistry Biophysiology Res Commun,. 2000; 271(2):342-345..
  67. Weldon CB, Burow ME, Beckman BS. Characterization of chemoresistance of MCF-7/ADR breast cancer cells. Proceedings of the Society of University Surgeons, Residents’ Conference. 2000.
  68. Rolfe K, Weldon CB, Burow ME, Beckman BS. MCF-7/ADR breast cancer cell chemonresistance. Proceedings of the American Association of Cancer Research. 2000.
  69. Burow ME, Weldon CB, Tang Y, Navar GL, Krajewski S, Reed JC, Hammond TG, Clejan S, Beckman BS. Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res. 1998 Nov 1; 58(21):4940-6.
  70. Burow, ME, Weldon CB, McKee A, Clejan S, Beckman BS. Phorbol ester and insulin-like growth factor-I suppression of TNF-á-induced apoptosis through a phosphatidylinositol-3-kinase mediated inhibition of ceramide formation and caspase activation. Proceedings of the American Association for Cancer Research special conference on Molecular Mechanisms of Apoptosis Regulation. 1998.
  71. Weldon C, Jones B, Daroca P, Beech D. Breast Leiomyoma. Journal of Louisiana State Medical Society. 1998; 150(8):367-370..
  72. Burrow M, Weldon C, Tang Y, Navar G, Krajewski S, Reed J, Hammond T, Clejan S, Beckman B. Differences in susceptibility to tumor necrosis factor á-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Research,. 1998; 58:4940-4946..
  73. Weldon C, Burow M, Tang Y, Navar G, Krajewski S, Reed J, Hammond T, Clejan S, Beckman B . MCF-7 breast cancer cell variants display differences in tumor necrosis factor á-included apoptosis. Proceedings of the Society of University Surgeons, Residents’ Conference. 1998.
  74. Burrow M, Weldon C, Collins-Burow BM, Ramsey N, McKee A, Klippel A, McLachlan JA, Clejan S, Bechman BS. Cross-talk between phosphatidylinositol-3 kinase and sphingomyelinase pathways as a mechanism for cell survival/death decisions. Journal of Biology and Chemistry,. 1998; 275(13):9628-9635..
  75. Burow ME, Weldon CB, Tang Y, Navar GL, Krajewski S, Reed JC, Hammond TG, Clejan S and Beckman BS . Differences in susceptibility to tumor necrosis factor- á-induced apoptosis among MCF-7 breast cancer cell variants. Proceedings of the American Association for Cancer Research. 1998.
  76. Seltzer B, Cola MG, Gutierrez C, Massee M, Weldon C, Cusick CG. Overlapping and nonoverlapping cortical projections to cortex of the superior temporal sulcus in the rhesus monkey: double anterograde tracer studies. J Comp Neurol. 1996 Jun 24; 370(2):173-90.
  77. Seltzer B, Cola M, Weldon C, Massee M, Cusick C. Parvalbumin staining delineates superior temporal polymodal cortex in Macaca mulatta. Proceedings of the Society of Neuroscience. 1993; (19):972.
  78. Seltzer B, Cola M, Massee M, Weldon C, Cusick C . Organization of cortical projections to the superior temporal polymodal cortex of the rhesus: double anterograde labeling studies. Proceedings of the Society of Neuroscience. 1992; (18):295.
  79. Rousou J, Levitsky S, Gonzalez-Lavin L, Cosgrove D, Magilligan D, Weldon C, Hiebert C, Hess P, Joyce L, Bergsland J, et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. J Thorac Cardiovasc Surg. 1989 Feb; 97(2):194-203.
  80. Laschinger JC, Vannier MW, Gutierrez F, Gronemeyer S, Weldon CS, Spray TL, Cox JL. Preoperative three-dimensional reconstruction of the heart and great vessels in patients with congenital heart disease. Technique and initial results. J Thorac Cardiovasc Surg. 1988 Sep; 96(3):464-73.
  81. Gutweiler JR, Yu DC, Kim HB, Kozakewich HP, Marcus KJ, Shamberger RC, Weldon CB. Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma. J Pediatr Surg. 2008 Dec; 43(12):2297-300.
  82. Zhou C, Nitschke AM, Xiong W, Zhang Q, Tang Y, Bloch M, Elliott S, Zhu Y, Bazzone L, Yu D, Weldon CB, Schiff R, McLachlan JA, Beckman BS, Wiese TE, Nephew KP, Shan B, Burow ME, Wang G. Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype. Breast Cancer Res. 2008; 10(6):R105.
  83. Lee EY, Tracy DA, Mahmood SA, Weldon CB, Zurakowski D, Boiselle PM. Preoperative MDCT evaluation of congenital lung anomalies in children: comparison of axial, multiplanar, and 3D images. AJR Am J Roentgenol. 2011 May; 196(5):1040-6.
  84. Weldon CB, Scandurro AB, Rolfe KW, Clayton JL, Elliott S, Butler NN, Melnik LI, Alam J, McLachlan JA, Jaffe BM, Beckman BS, Burow ME. Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray. Surgery. 2002 Aug; 132(2):293-301.
  85. Scandurro AB, Weldon CW, Figueroa YG, Alam J, Beckman BS. Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells. Int J Oncol. 2001 Jul; 19(1):129-35.
  86. Yu DC, Voss SD, Javid PJ, Jennings RW, Weldon CB. In utero diagnosis of congenital pyloric atresia in a single twin using MRI and ultrasound. J Pediatr Surg. 2009 Nov; 44(11):e21-4.
  87. Klint R, Weldon C, Hartmann A, Schad N, Hernandez A, Goldring D. Mexed-type total anomalous pulmonary venous drainage. Report of a successful surgical correction and review of the literature. J Thorac Cardiovasc Surg. 1972 Jan; 63(1):164-70.
  88. Bratton MR, Duong BN, Elliott S, Weldon CB, Beckman BS, McLachlan JA, Burow ME. Regulation of ERalpha-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: implications for breast cancer cell survival. Int J Oncol. 2010 Sep; 37(3):541-50.
  89. Collins-Burow BM, Antoon JW, Frigo DE, Elliott S, Weldon CB, Boue SM, Beckman BS, Curiel TJ, Alam J, McLachlan JA, Burow ME. Antiestrogenic activity of flavonoid phytochemicals mediated via the c-Jun N-terminal protein kinase pathway. Cell-type specific regulation of estrogen receptor alpha. J Steroid Biochem Mol Biol. 2012 Oct; 132(1-2):186-93.
  90. Madenci AL, Stetson A, Weldon CB, Lehmann LE. Safety of peritoneal and pleural drain placement in pediatric stem cell transplant recipients with severe veno-occlusive disease. Pediatr Transplant. 2016 Aug; 20(5):687-91.
  91. Vadva Z, Laufer MR, Weldon CB, Frazier AL, Vargas SO. Diagnostic Impact of Peritoneal Fluid Cytology in the Setting of Pediatric Uterine Adnexal Biopsy or Resection. Pediatr Dev Pathol. 2016 Sep/Oct; 19(5):401-408.
To schedule an appointment: Call 617-355-4503 or Request an Appointment

Locations

We are grateful to have been ranked #1 on U.S. News & World Report's list of the best children's hospitals in the nation for the third year in a row, an honor we could not have achieved without the patients and families who inspire us to do our very best for them. Thanks to you, Boston Children's is a place where we can write the greatest children's stories ever told.”
- Sandra L. Fenwick, President and CEO

Boston Children's Hospital 300 Longwood Avenue, Boston, MA 02115 617-355-6000 | 800-355-7944

Close